2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | - | - | 402.818 | 1.094.621 | 1.686.866 | 1.774.100 |
Total Income - EUR | - | - | - | - | - | - | 402.862 | 1.094.727 | 1.691.085 | 1.794.717 |
Total Expenses - EUR | - | - | - | - | - | - | 379.108 | 1.047.655 | 1.568.009 | 1.783.895 |
Gross Profit/Loss - EUR | - | - | - | - | - | - | 23.755 | 47.072 | 123.076 | 10.822 |
Net Profit/Loss - EUR | - | - | - | - | - | - | 19.726 | 39.791 | 107.228 | 3.755 |
Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nutrapharm S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 6.621 | 21.064 | 35.410 | 50.952 | - | - | - | - | - | - |
Current Assets | - | - | - | - | - | - | 746.955 | 828.143 | 1.164.534 | 1.401.236 |
Inventories | - | - | - | - | - | - | 0 | 0 | 24.778 | 208.889 |
Receivables | - | - | - | - | - | - | 746.088 | 719.074 | 1.135.070 | 1.181.359 |
Cash | - | - | - | - | - | - | 867 | 109.069 | 4.686 | 10.988 |
Shareholders Funds | - | - | - | - | - | - | 19.768 | 52.737 | 147.791 | 92.076 |
Social Capital | - | - | - | - | - | - | 41 | 40 | 40.556 | 40.433 |
Debts | - | - | - | - | - | - | 778.139 | 810.816 | 1.037.930 | 1.333.329 |
Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4639 - 4639" | |||||||||
CAEN Financial Year | 4646 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.